Effect of Knee Bracing on Improving Pain & Disability

Effect of Knee Bracing on Improving Pain & Disability, Physical Performance, Physical Activity and Femoral Cartilage Deformation in Individuals With Medial Compartment Knee Osteoarthritis

The overall purpose of the proposed pilot study is to establish the feasibility of conducting a clinical trial by evaluating the preliminary effects of 8 weeks of knee bracing on physiological measures of self-reported pain and disability, physical performance, physical activity, as well as femoral cartilage deformation in individuals with medial compartment knee osteoarthritis (OA). The investigators will recruit 36 symptomatic knee OA patients for the pilot study. The investigators will evaluate a class of braces (two different models will be used) designed to correct genu varum. The purpose of the study is to evaluate changes in these novel outcomes following the use of a class of braces used to reduce medial tibiofemoral compartment compression used for 8 weeks. This pilot study will inform a larger future trial to determine the efficacy of bracing on decreasing disability and disease progression in patients with knee osteoarthritis.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

31

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • North Carolina
      • Chapel Hill, North Carolina, United States, 27599
        • MOTION Science Institute

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

40 years to 75 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

Participants must:

  • have a physician diagnosis of knee OA in the medial compartment and exhibit symptomatic knee OA, which the investigators will define as a normalized, person based, Western Ontario and McMaster Universities Arthritis Index (WOMAC) function subscale score > 31 (out of 100 points, indicating most dysfunction).
  • have had a knee radiograph taken within the previous 6 months.
  • be between the ages of 40 and 75 years old will be included.

Exclusion Criteria:

Participants will be excluded if they have:

  • been diagnosed with a cardiovascular condition restricting exercise;
  • had a corticosteroid or hyaluronic acid injection in the involved knee in the previous 2 weeks;
  • a pacemaker;
  • a neurodegenerative condition;
  • rheumatoid arthritis;
  • cancer;
  • neural sensory dysfunction over the knee;
  • a BMI over 35;
  • history of lower extremity orthopaedic surgery in the past year;
  • a history of a traumatic knee injury in the past 6 months;
  • any history of a total knee arthroplasty in either extremity; or
  • a diagnosed, non-reconstructed knee ligament tear.
  • the need of an assistive device to walk.

The investigators will also exclude pregnant women, as well as women who are trying to get pregnant or plan to get pregnant during the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Medial Unloader Brace
medial knee unloader braces use a three point bending system to increase space in the medial tibiofemoral compartment during weight bearing

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Percentage Change in WOMAC Function score from Baseline to 8 weeks
Time Frame: Baseline, Week 8 (Followup)
The Western Ontario and McMasters Osteoarthritis Index (WOMAC) is a self-reported measure of disability. The physical function consists of 17 items and asks about the magnitude of difficulty when ascending and descending stairs, rising from sitting, standing, bending, walking, getting in/out of a car, shopping, putting on and taking off socks, rising from bed, lying in bed, getting in and out of the bath, sitting, getting on and off the toilet, completing heavy household duties, and completing light household duties. Each item is presented in a 5 point Likert-type format and uses the following descriptors for possible answer choices none, mild moderate, severe, and extreme. Each descriptor corresponds to an ordinal scale of 0-4. The scores are summed for the items in each subscale, with a total possible range from 0-68. Higher scores indicate greater amounts of functional limitations.
Baseline, Week 8 (Followup)
Percentage Change in Physical Activity Scale for the Elderly from Baseline to 8 weeks
Time Frame: Baseline, Week 8 (Followup)
Physical Activity Scale for the Elderly (PASE) scores are calculated from weights and frequency values for each of 12 types of activity. Responses to the first question about sitting activities are not scored. The scale is continuous with higher scores indicating greater physical activity
Baseline, Week 8 (Followup)
Percentage Change in 30-s chair-stand test from Baseline to 8 weeks
Time Frame: Baseline, Week 8 (Followup)
The number of times that an individual can sit and stand in 30 seconds.
Baseline, Week 8 (Followup)
Percentage Change in 20 meter fast-paced walk test from Baseline to 8 weeks
Time Frame: Baseline, Week 8 (Followup)
The investigators will time the amount of seconds it takes to walk 20 meters.
Baseline, Week 8 (Followup)
Percentage Change in Stair-climb test from Baseline to 8 weeks
Time Frame: Baseline, Week 8 (Followup)
The investigators will time the amount of seconds it takes to walk up and down a flight of stairs.
Baseline, Week 8 (Followup)
Percentage Change in Femoral Cartilage Cross-sectional area from Baseline to 8 weeks
Time Frame: Baseline, Week 8 (Followup)
The investigators will measure the amount of cartilage cross-sectional area on the anterior femur before and after 3000 steps of walking. A greater change in cross-sectional area is determined to be more more cartilage deformation.
Baseline, Week 8 (Followup)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Brian Pietrosimone, University of North Carolina, Chapel Hill

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 1, 2018

Primary Completion (Actual)

March 31, 2020

Study Completion (Actual)

March 31, 2020

Study Registration Dates

First Submitted

August 1, 2019

First Submitted That Met QC Criteria

August 1, 2019

First Posted (Actual)

August 5, 2019

Study Record Updates

Last Update Posted (Actual)

March 8, 2021

Last Update Submitted That Met QC Criteria

March 5, 2021

Last Verified

March 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • 18-2363

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Deidentified individual data that supports the results will be shared beginning 9 to 36 months following publication provided the investigator who proposes to use the data has approval from an Institutional Review Board (IRB), Independent Ethics Committee (IEC), or Research Ethics Board (REB), as applicable, and executes a data use/sharing agreement with UNC

IPD Sharing Time Frame

9 to 36 months following publication

IPD Sharing Access Criteria

Investigator who proposes to use the data has IRB, IEC, or REB approval and executed a data use/sharing agreement with UNC.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Knee Osteoarthritis

Clinical Trials on Medial Unloader Brace

Subscribe